Chen-Hsu Wang1,2, Hui-Wen Yang3, Han-Luen Huang1,4, Cheng-Yi Hsiao1, Bun-Kai Jiu1, Chen Lin1,5, Men-Tzung Lo1,5. 1. Institute of Translational and Interdisciplinary Medicine, National Central University, Taoyuan. 2. General Cardiology & Coronary Care Unit, Cardiovascular Center, Cathay General Hospital. 3. Graduate Institute of Communication Engineering, National Taiwan University, Taipei. 4. Department of Cardiology, Hsinchu Cathay General Hospital, Hsinchu. 5. Center for Biotechnology and Biomedical Engineering, National Central University, Taoyuan, Taiwan.
Abstract
BACKGROUND: Hypertension is related to autonomic nervous system (ANS) dysfunction, atherosclerosis and chronic inflammation. The stimulation of baroreflex regulation by slow-breathing exercise may improve the interplay among these systems. The objective of this study was to investigate the effect of device-guided slow breathing on ANS, cardiovascular system and chronic inflammation in hypertensive patients. METHODS: We prospectively collected 36 essential hypertension patients who were requested to practice slow-breathing exercise 5 times per day for 3 months. The breathing exercise was guided by a cellphone app with a wearable electrocardiography device and a rhythm of 6 cycles per minute. Cardiovascular indicators including heart rate variability (HRV), blood pressure, pulse wave velocity and baroreflex indexes were sampled 3 times: at the first visit, and 1 month and 3 months after the intervention. The levels of blood inflammatory biomarkers, including tumor necrosis factor-alpha (TNF-α), interleukin-6, interleukin-1 receptor antagonist and C-reactive protein were also collected at all 3 visits. The longitudinal differences in these variables and their correlations were tested. RESULTS: There was a significant decrease in blood pressure after 1 month of exercise. A significantly continuous decrease in TNF-α was also observed. The baroreflex indexes were significantly increased in the acute intervention of slow-breathing but not in the longitudinal effect. The HRV variables did not show differences with time. There were positive correlations between sympathetic index and TNF-α and galectin-3. CONCLUSIONS: The effect of slow-breathing exercise on blood pressure and chronic inflammation was significant. HRV indexes may also be used to assess chronic inflammation.
BACKGROUND: Hypertension is related to autonomic nervous system (ANS) dysfunction, atherosclerosis and chronic inflammation. The stimulation of baroreflex regulation by slow-breathing exercise may improve the interplay among these systems. The objective of this study was to investigate the effect of device-guided slow breathing on ANS, cardiovascular system and chronic inflammation in hypertensive patients. METHODS: We prospectively collected 36 essential hypertension patients who were requested to practice slow-breathing exercise 5 times per day for 3 months. The breathing exercise was guided by a cellphone app with a wearable electrocardiography device and a rhythm of 6 cycles per minute. Cardiovascular indicators including heart rate variability (HRV), blood pressure, pulse wave velocity and baroreflex indexes were sampled 3 times: at the first visit, and 1 month and 3 months after the intervention. The levels of blood inflammatory biomarkers, including tumor necrosis factor-alpha (TNF-α), interleukin-6, interleukin-1 receptor antagonist and C-reactive protein were also collected at all 3 visits. The longitudinal differences in these variables and their correlations were tested. RESULTS: There was a significant decrease in blood pressure after 1 month of exercise. A significantly continuous decrease in TNF-α was also observed. The baroreflex indexes were significantly increased in the acute intervention of slow-breathing but not in the longitudinal effect. The HRV variables did not show differences with time. There were positive correlations between sympathetic index and TNF-α and galectin-3. CONCLUSIONS: The effect of slow-breathing exercise on blood pressure and chronic inflammation was significant. HRV indexes may also be used to assess chronic inflammation.
Authors: Monique B Nilsson; Guillermo Armaiz-Pena; Rie Takahashi; Yvonne G Lin; Jose Trevino; Yang Li; Nicholas Jennings; Jesusa Arevalo; Susan K Lutgendorf; Gary E Gallick; Angela M Sanguino; Gabriel Lopez-Berestein; Steven W Cole; Anil K Sood Journal: J Biol Chem Date: 2007-08-23 Impact factor: 5.157
Authors: V Gunterberg; M Simrén; L Öhman; P Friberg; M P Jones; L Van Oudenhove; H Strid Journal: Neurogastroenterol Motil Date: 2016-06-06 Impact factor: 3.598
Authors: Elisabeth Maria Balint; Beate Grüner; Sophia Haase; Mandakini Kaw-Geppert; Julian F Thayer; Harald Gündel; Marc N Jarczok Journal: Front Immunol Date: 2022-10-03 Impact factor: 8.786